Engineering large-scale chromosomal deletions by CRISPR-Cas9

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Large-scale chromosomal deletions are common in cancer, suggesting they provide a selective oncogenic advantage.
• Identifying specific oncogenic drivers within these large deletions is challenging due to their size.
• Limited functional genomics tools exist for studying the impact of large deletions.

Purpose of the Study:

• To develop an effective CRISPR-Cas9 based technique for engineering large-scale chromosomal deletions.
• To create isogenic cell line models harboring these deletions for functional studies.
• To investigate the oncogenic role and therapeutic potential of large deletions.

Main Methods:

• Simultaneous induction of double-strand breaks (DSBs) at two chromosomal locations using CRISPR-Cas9.
• Selection of cells with the intervening chromosomal region deleted.
• Application of the technique to engineer 65 Mb deletions on chromosome 11q and 53 Mb deletions on chromosome 6q in neuroblastoma cell lines.

Main Results:

• Successful engineering of large-scale deletions with a high frequency (up to 30% of selected clones).
• Neuroblastoma cell lines with 11q deletions exhibited increased colony-forming capacity, suggesting an oncogenic advantage.
• The developed method effectively generated isogenic cell line models for studying large deletions.

Conclusions:

• The CRISPR-Cas9 technique provides an effective means to engineer large chromosomal deletions and create valuable isogenic models.
• Large deletions, such as those on chromosome 11q, can confer an oncogenic advantage in cancer.
• These isogenic models are crucial for further research into the role of large deletions in tumorigenesis and their therapeutic implications.